Taken together, our findings demonstrated that RA inhibits proliferation, invasion and migration of cervical cancer cells via regulating miR-224-3p/Slit2/Robo1 signaling pathway, which indicates that RA can be an effective drug for CC therapies by targeting miR-224-3p and its downstream effectors. Here, ROBO1 is linked to cervical carcinoma.